the aid library

Gavi Alliance MS Roadmap for Oral Cholera Vaccines 4: The Market Shaping Goal Ensure healthy markets for vaccines and related products

GAVI Alliance (2023) C1

Geneva, 22 May 2023 – Gavi, the Vaccine Alliance today published a roadmap* outlining critical ... more

Ebola vaccine purchasing commitment from Gavi to prepare for future outbreaks

GAVI The Vaccine Alliance (2016) C1

The malaria vaccine

GAVI The Vaccine Alliance (2025) CC

A VaccinesWork guide: news, science explainers and reported dispatches giving you everything you need to know about the world’s first malaria vaccine and its historic roll-out.

Break COVID Now: The Gavi COVAX AMC Investment Opportunity

Gavi, the Vaccine Alliance (2022) CC

In April 2020, Gavi and COVAX joined the Access to COVID-19 Tools Accelerator (ACT-A) to provide equitable global access to COVID-19 vaccines to tackle th ... more

Global Vaccine Summit 2020 - Chair’s Summary

Global Alliance for Vaccines and Immunisation (Gavi) Global Alliance for Vaccines and Immunisation (Gavi) (2020) CC

The UK government hosted the Global Vaccine Summit on June 4, 2020 under the patronage of ... more

Expanding sustainable vaccine manufacturing in Africa: Priorities for Support

GAVI Alliance (2022) C1

Despite high regional demand for vaccines valued at over US$ 1 billion annually, Africa’s vaccine industry provides only 0.1% of global supply. Vaccine inequity and hoarding at ... more

Resource Catalogue forService Quality and Experience Literature and Tools

GAVI The Vaccine Alliance (2020) CC

The Big Catch-Up: An Essential Immunization Recovery Plan for 2023 and Beyond

World Health Organisation (WHO) (2023) C_WHO

The backsliding of immunization coverage during the COVID-19 pandemic, combined with delayed catch-up efforts has resulted in a large and growing immunity gap. There is an urgent need to close this ... more

Accelerator Discussion Paper 1: Sustainable Financing

Global Fund, World Bank Group, Gavi, the Vaccine Alliance et al. World Health Organization (WHO) (2019) CC

The Global Action Plan for Healthy Lives and Well-being for All (SDG3 GAP) is a set of commitments by 13 multilateral agencies to strengthen their collaboration. For this purpose several accelerators were created and an invitation for public comment ... more

Estimates of aid for reproductive, maternal, newborn, and child health: findings from application of the Muskoka2 method, 2002–17

Dingle, A.; Schäferhoff, M.; Borghi, J. et al. The Lancet (2020) CC

Background Four methods have previously been used to track aid for reproductive, maternal, newborn, and child health (RMNCH). At a meeting of donors and stakeholders in May, 2018, a single, agreed method was requested to produce accurate, predictable, transparent, and up-to-date estimates that coul ... d be used for analyses from both donor and recipient perspectives. Muskoka2 was developed to meet these needs. We describe Muskoka2 and present estimates of levels and trends in aid for RMNCH in 2002–17, with a focus on the latest estimates for 2017. Methods Muskoka2 is an automated algorithm that generates disaggregated estimates of aid for reproductive health, maternal and newborn health, and child health at the global, donor, and recipient-country levels. We applied Muskoka2 to the Organisation for Economic Co-operation and Development's Creditor Reporting System (CRS) aid activities database to generate estimates of RMNCH disbursements in 2002–17. The percentage of disbursements that benefit RMNCH was determined using CRS purpose codes for all donors except Gavi, the Vaccine Alliance; the UN Population Fund; and UNICEF; for which fixed percentages of aid were considered to benefit RMNCH. We analysed funding by donor for the 20 largest donors, by recipient-country income group, and by recipient for the 16 countries with the greatest RMNCH need, defined as the countries with the worst levels in 2015 on each of seven health indicators. Findings After 3 years of stagnation, reported aid for RMNCH reached $15·9 billion in 2017, the highest amount ever reported. Among donors reporting in both 2016 and 2017, aid increased by 10% ($1·4 billion) to $15·4 billion between 2016 and 2017. Child health received almost half of RMNCH disbursements in 2017 (46%, $7·4 billion), followed by reproductive health (34%, $5·4 billion), and maternal and newborn health (19%, $3·1 billion). The USA ($5·8 billion) and the UK ($1·6 billion) were the largest bilateral donors, disbursing 46% of all RMNCH funding in 2017 (including shares of their core contributions to multilaterals). The Global Fund and Gavi were the largest multilateral donors, disbursing $1·7 billion and $1·5 billion, respectively, for RMNCH from their core budgets. The proportion of aid for RMNCH received by low-income countries increased from 31% in 2002 to 52% in 2017. Nigeria received 7% ($1·1 billion) of all aid for RMNCH in 2017, followed by Ethiopia (6%, $876 million), Kenya (5%, $754 million), and Tanzania (5%, $751 million). Interpretation Muskoka2 retains the speed, transparency, and donor buy-in of the G8's previous Muskoka approach and incorporates eight innovations to improve precision. Although aid for RMNCH increased in 2017, low-income and middle-income countries still experience substantial funding gaps and threats to future funding. Maternal and newborn health receives considerably less funding than reproductive health or child health, which is a persistent issue requiring urgent attention. Funding Bill & Melinda Gates Foundation; Partnership for Maternal, Newborn & Child Health. more

Catalyzing solutions for equitable global access and sustainable financing for novel tuberculosis vaccines for adults and adolescents

World Health Organization WHO (2025) C_WHO

This report was developed by the WHO TB Vaccine Accelerator Finance and Access working group, co-led by WHO, Gavi and ... more

Financing Global Health 2013: Transition in an Age of Austerity

Institute for Health Metrics and Evaluation (2014) CC

Financing Global Health 2013: Transition in an Age of Austerity, IHME’s fifth annual report on global health expenditure, depicts financing trends that underline the resilience of development assistance for health. This year’s updated estimates ... more

UNICEF, WHO, IFRC and MSF announce the establishment of a global Ebola vaccine stockpile

World Health Organization WHO; et al. (2021) C_WHO

12 January 2021

The Critical Role of Community Health Workers in COVID-19 Vaccine Roll Out
recommended

African Union; Africa CDC Centres for Disease Control and Prevention (2021) CC

Since the emergence of COVID 19 in December 2019, various public health responses measures have been implemented to control the pandemic. Among measures taken by ... more

Preliminary results on the efficacy of rVSV-ZEBOV-GP Ebola vaccine using the ring vaccination strategy in the control of anEbola outbreak in the Democratic Republic of the Congo

World Health Organization WHO (2019) C_WHO

An example of integration of research into epidemic response.

The HIV response in conflict: Lessons learnt from South Sudan

Geofrey Odongkara, Cecilia Kihara, Jane Johnson, Hester Phillips International HIVAIDS Alliance; POZ (2014)

Case Study

Business case for WHO immunization activities on the African continent 2018-2030

World Health Organization (WHO) (2018) C_WHO

The Global Vaccine Action Plan (GVAP) 2011-2020, endorsed by Member States during the May 2012 World Health Assembly, has set ambitious targets to ... more

Surveillance tools for meningitis sentinel hospital surveillance: field guide to rapidly estimate the hospital catchment population (denominator) and the annual rate of hospitalisations

World Health Organization WHO (2015) C_WHO

The document will provide information for Ministries of Health and hospital sentinel sites on why and how to determine the denominator of at-risk children <5 years of age and rate of meningitis hospitalizations for a sentinel hospital site conducting IB-VPD surveillance. Such a methodology is currently unavailable and this estimation is critical to enable interpretation of surveillance data, particularly pre- and post- ... more

Global vaccine market report 2022: a shared understanding for equitable access to vaccines

World Health Organisation (WHO) (2023) C_WHO

The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustaina ... more